X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (83) 83
humans (69) 69
human necessities (55) 55
hygiene (55) 55
medical or veterinary science (55) 55
female (51) 51
male (50) 50
preparations for medical, dental, or toilet purposes (44) 44
specific therapeutic activity of chemical compounds ormedicinal preparations (39) 39
middle aged (37) 37
aged (34) 34
rivaroxaban (27) 27
adult (25) 25
risk factors (25) 25
anticoagulants (22) 22
cardiac & cardiovascular systems (21) 21
atrial fibrillation (20) 20
anticoagulants - therapeutic use (19) 19
prevention (18) 18
prospective studies (18) 18
stroke (18) 18
venous thromboembolism (18) 18
hematology (17) 17
peripheral vascular disease (17) 17
treatment outcome (17) 17
abridged index medicus (16) 16
aged, 80 and over (16) 16
animals (16) 16
thromboembolism (16) 16
double-blind method (15) 15
factor xa inhibitors (15) 15
inflammatory bowel disease (15) 15
administration, oral (14) 14
drug therapy (14) 14
surgery (14) 14
anticoagulants - administration & dosage (13) 13
gastroenterology & hepatology (13) 13
anticoagulants - adverse effects (12) 12
bay-59-7939 (12) 12
crohns-disease (12) 12
deep-vein thrombosis (12) 12
management (12) 12
medicine, general & internal (12) 12
patients (12) 12
prevalence (12) 12
ulcerative-colitis (12) 12
atrial fibrillation - drug therapy (11) 11
chemical aspects of bandages, dressings, absorbent pads, orsurgical articles (11) 11
disinfection, sterilisation, or deodorisation of air (11) 11
enoxaparin (11) 11
factor-xa inhibitor (11) 11
hemorrhage (11) 11
hemorrhage - chemically induced (11) 11
materials for bandages, dressings, absorbent pads, or surgicalarticles (11) 11
methods or apparatus for sterilising materials or objects ingeneral (11) 11
morpholines - administration & dosage (11) 11
morpholines - therapeutic use (11) 11
thiophenes - administration & dosage (11) 11
thiophenes - therapeutic use (11) 11
adolescent (10) 10
care and treatment (10) 10
chemistry (10) 10
diagnosis (10) 10
internal medicine (10) 10
pharmacodynamics (10) 10
registries (10) 10
risk (10) 10
therapy (10) 10
time factors (10) 10
ulcerative colitis (10) 10
cardiovascular (9) 9
morpholines - adverse effects (9) 9
mortality (9) 9
thiophenes - adverse effects (9) 9
thrombosis (9) 9
crohn's disease (8) 8
dose-response relationship, drug (8) 8
heart failure (8) 8
inflammatory-bowel-disease (8) 8
metallurgy (8) 8
molecular-weight heparin (8) 8
organic chemistry (8) 8
pharmacokinetics (8) 8
prognosis (8) 8
warfarin (8) 8
arthroplasty (7) 7
bay 59-7939 (7) 7
cardiac arrhythmia (7) 7
enoxaparin - adverse effects (7) 7
enoxaparin - therapeutic use (7) 7
factor xa (7) 7
fibrinolytic agents - therapeutic use (7) 7
follow-up studies (7) 7
health aspects (7) 7
heterocyclic compounds (7) 7
medical research (7) 7
patient outcomes (7) 7
risk-factors (7) 7
venous thromboembolism - prevention & control (7) 7
venous thrombosis (7) 7
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (192) 192
French (14) 14
German (11) 11
Spanish (6) 6
Chinese (5) 5
Portuguese (4) 4
Norwegian (2) 2
Croatian (1) 1
Danish (1) 1
Greek (1) 1
Hungarian (1) 1
Russian (1) 1
Slovenian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Anand, Sonia S and Bosch, Jackie and Eikelboom, John W and Connolly, Stuart J and Diaz, Rafael and Widimsky, Peter and Aboyans, Victor and Alings, Marco and Kakkar, Ajay K and Keltai, Katalin and Maggioni, Aldo P and Lewis, Basil S and Störk, Stefan and Zhu, Jun and Lopez-Jaramillo, Patricio and O'Donnell, Martin and Commerford, Patrick J and Vinereanu, Dragos and Pogosova, Nana and Ryden, Lars and Fox, Keith A A and Bhatt, Deepak L and Misselwitz, Frank and Varigos, John D and Vanassche, Thomas and Avezum, Alvaro A and Chen, Edmond and Branch, Kelley and Leong, Darryl P and Bangdiwala, Shrikant I and Hart, Robert G and Yusuf, Salim and SALA, JORGELINA and CARTASEGNA, LUIS and VICO, MARISA and HOMINAL, MIGUEL ANGEL and HASBANI, EDUARDO and CACCAVO, ALBERTO and ZAIDMAN, CESAR and VOGEL, DANIEL and HRABAR, ADRIAN and SCHYGIEL, PABLO OMAR and CUNEO, CARLOS and LUQUEZ, HUGO and MACKINNON, IGNACIO J and AHUAD GUERRERO, RODOLFO ANDRES and COSTABEL, JUAN PABLO and BARTOLACCI, INES PALMIRA and MONTANA, OSCAR and BARBIERI, MARIA and GOMEZ VILAMAJO, OSCAR and GARCIA DURAN, RUBEN OMAR and SCHIAVI, LILIA BEATRIZ and GARRIDO, MARCELO and INGARAMO, ADRIAN and BORDONAVA, ANSELMO PAULINO and PELAGAGGE, MARIA JOSE and NOVARETTO, LEONARDO and ALBISU DI GENNERO, JUAN PABLO and IBANEZ SAGGIA, LUZ MARIA and ALVAREZ, MOIRA and VITA, NESTOR ALEJANDRO and MACIN, STELLA MARIS and DRAN, RICARDO DARIO and CARDONA, MARCELO and GUZMAN, RANDOLPH and GUZMAN, LUIS and SARJANOVICH, RODOLFO JUAN and CUADRADO, JESUS and NANI, SEBASTIAN and LITVAK BRUNO, MARCOS RAUL and CHACON, CAROLINA and MAFFEI, LAURA ELENA and GRINFELD, DIEGO and VENSENTINI, NATALIA and MAJUL, CLAUDIO RODOLFO and LUCIARDI, HECTOR LUCAS and GONZALEZ COLASO, PATRICIA DEL CARMEN and FERRE PACORA, FREDY ANTONI and VAN DEN HEUVEL, PAUL and VERHAMME, PETER and ECTOR, BAVO and DEBONNAIRE, PHILIPPE and VAN DE BORNE, PHILIPPE and LEROY, JEAN and SCHROE, HERMAN and VRANCKX, PASCAL and ELEGEERT, IVAN and HOFFER, ETIENNE and DUJARDIN, KARL and INDIO DO BRASIL, CLARISSE and PRECOMA, DALTON and ABRANTES, JOSE ANTONIO and MANENTI, EULER and REIS, GILMAR and SARAIVA, JOSE and MAIA, LILIA and HERNANDES, MAURO and ROSSI, PAULO and ROSSI DOS SANTOS, FABIO and ... and COMPASS Investigators
The Lancet, ISSN 0140-6736, 01/2018, Volume 391, Issue 10117, pp. 219 - 229
Patients with peripheral artery disease have an increased risk of cardiovascular morbidity and mortality. Antiplatelet agents are widely used to reduce these... 
MORTALITY | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | MANAGEMENT | THERAPY | OUTPATIENTS | CARDIOVASCULAR EVENT RATES | PREVENTION | RISK | Myocardial Infarction - epidemiology | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Carotid Artery Diseases - complications | Male | Peripheral Arterial Disease - complications | Rivaroxaban - administration & dosage | Aspirin - administration & dosage | Factor Xa Inhibitors - administration & dosage | Incidence | Dose-Response Relationship, Drug | Rivaroxaban - adverse effects | Aspirin - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - mortality | Female | Stroke - epidemiology | Aspirin - therapeutic use | Lower Extremity - surgery | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Myocardial Infarction - etiology | Rivaroxaban - therapeutic use | Carotid Artery Diseases - drug therapy | Platelet Aggregation Inhibitors - adverse effects | Stroke - prevention & control | Double-Blind Method | Drug Administration Schedule | Peripheral Arterial Disease - drug therapy | Carotid Artery Diseases - epidemiology | Morbidity | Factor Xa Inhibitors - therapeutic use | Stroke - etiology | Peripheral Arterial Disease - epidemiology | Factor Xa Inhibitors - adverse effects | Aged | Myocardial Infarction - prevention & control | Amputation - statistics & numerical data | Hemorrhage - chemically induced | Lower Extremity - blood supply | Cardiac arrhythmia | Anticoagulants | Aspirin | Stroke | Heart attacks | Medical imaging | Mortality | Clinical trials | Cardiovascular disease | Patients | Disease control | Carotid arteries | Disease prevention | Coronary vessels | Blood pressure | Carotid artery | Acute coronary syndromes | Thromboembolism | Health risk assessment | Index Medicus | Abridged Index Medicus
Journal Article
Heart, ISSN 1355-6037, 2017, Volume 103, Issue 4, pp. 307 - 314
Journal Article
Lancet, The, ISSN 0140-6736, 2008, Volume 372, Issue 9632, pp. 31 - 39
Summary Background The risk of venous thromboembolism is high after total hip arthroplasty and could persist after hospital discharge. Our aim was to compare... 
Internal Medicine | WEIGHT HEPARIN-PROPHYLAXIS | MEDICINE, GENERAL & INTERNAL | PLACEBO | FACTOR-XA INHIBITOR | ORTHOPEDIC-SURGERY | KNEE REPLACEMENT | BAY-59-7939 | THROMBOSIS | PROLONGED THROMBOPROPHYLAXIS | TIME-COURSE | DALTEPARIN | Thiophenes - therapeutic use | Double-Blind Method | Drug Administration Schedule | Thiophenes - adverse effects | Humans | Middle Aged | Morpholines - administration & dosage | Arthroplasty, Replacement, Hip | Male | Thiophenes - administration & dosage | Enoxaparin - therapeutic use | Enoxaparin - adverse effects | Fibrinolytic Agents - adverse effects | Rivaroxaban | Venous Thromboembolism - prevention & control | Enoxaparin - administration & dosage | Fibrinolytic Agents - therapeutic use | Aged, 80 and over | Adult | Female | Aged | Fibrinolytic Agents - administration & dosage | Morpholines - adverse effects | Morpholines - therapeutic use | Health care | Medical imaging | Hospitals | Protease inhibitors | Surgery | Tomography | Joint surgery | Drug therapy | Patients | Veins & arteries | Index Medicus | Abridged Index Medicus | Thiophenes/administration & dosage/adverse effects/therapeutic use | use | Arthroplasty | Replacement | Venous Thromboembolism/prevention & control | Morpholines/administration & dosage/adverse effects/therapeutic use | Kirurgi | Hip | 80 and over | Enoxaparin/administration & dosage/adverse effects/therapeutic use | Fibrinolytic Agents/administration & dosage/adverse effects/therapeutic
Journal Article
Lancet, The, ISSN 0140-6736, 2009, Volume 373, Issue 9676, pp. 1673 - 1680
Summary Background Prophylaxis for venous thromboembolism is recommended for at least 10 days after total knee arthroplasty; oral regimens could enable shorter... 
Internal Medicine | XIMELAGATRAN | PROPHYLAXIS | MEDICINE, GENERAL & INTERNAL | HIP-ARTHROPLASTY | DIRECT THROMBIN INHIBITOR | VENOUS THROMBOEMBOLISM | MOLECULAR-WEIGHT HEPARIN | MAJOR ORTHOPEDIC-SURGERY | DOUBLE-BLIND | PREVENTION | Thiophenes - therapeutic use | Arthroplasty, Replacement, Knee - adverse effects | Follow-Up Studies | Thiophenes - adverse effects | Humans | Middle Aged | Venous Thrombosis - diagnostic imaging | Male | Enoxaparin - therapeutic use | Incidence | Rivaroxaban | Sensitivity and Specificity | Female | Venous Thrombosis - prevention & control | Morpholines - adverse effects | Morpholines - therapeutic use | Double-Blind Method | Hemorrhage - epidemiology | Risk Reduction Behavior | Administration, Oral | Anticoagulants - therapeutic use | Treatment Outcome | Venous Thrombosis - etiology | Phlebography | Analysis of Variance | Venous Thrombosis - epidemiology | Aged | Hemorrhage - chemically induced | Prevention | Enoxaparin | Anticoagulants (Medicine) | Dosage and administration | Thrombophlebitis | Comparative analysis | Risk factors | Studies | Blood transfusions | Sensitivity analysis | Medical imaging | Hospitals | Protease inhibitors | Surgery | Joint surgery | Drug therapy | Thrombosis | Patients | Veins & arteries | Index Medicus | Abridged Index Medicus | Knee | Venous Thrombosis | Oral | Hemorrhage | epidemiology | Thiophenes | Administration | Anticoagulants | chemically induced | Arthroplasty | Replacement | prevention & control | radiography | Morpholines | Kirurgi | etiology | adverse effects | therapeutic use
Journal Article
BMC Pharmacology and Toxicology, ISSN 2050-6511, 12/2015, Volume 16, Issue S1
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2008, Volume 358, Issue 26, pp. 2776 - 2786
Journal Article
Journal Article
Journal Article